Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Panza

Showing results (1-10 of 404) with videos related to

Pageof 41
Sort By:
Drugs|July 21, 2017
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in SpasticityAndrea Santamato, Francesco Panza
The Lancet. Neurology|December 14, 2016
Anti-tau vaccine in Alzheimer's disease: a tentative stepFrancesco Panza, Giancarlo Logroscino
Journal of Alzheimer'S Disease : JAD|October 30, 2014
Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extractVincenzo Solfrizzi, Francesco Panza
The Lancet. Healthy Longevity|September 12, 2022
A multidimensional frailty approach in predicting and preventing dementiaMadia Lozupone, Francesco Panza
Epigenomics|May 13, 2020
Social determinants of late-life depression epigeneticsMadia Lozupone, Francesco Panza
Nature Reviews. Neurology|August 8, 2022
The challenges of anti-tau therapeutics in Alzheimer diseaseFrancesco Panza, Madia Lozupone
Neuroepidemiology|April 23, 2016
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition In Older AgeGiancarlo Logroscino, Francesco Panza
Journal of Alzheimer'S Disease : JAD|November 26, 2013
Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?Vincenzo Solfrizzi, Francesco Panza
Neural Regeneration Research|July 25, 2023
Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid betaMadia Lozupone, Francesco Panza
European Geriatric Medicine|February 27, 2024
Multidimensional complex frailty phenotypes: epidemiological impact of oral frailty in older ageFrancesco Panza, Madia Lozupone, Vittorio Dibello
Pageof 41

Showing results (1-10 of 404) with videos related to

Sort By:
Pageof 41
Drugs|July 21, 2017
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in SpasticityAndrea Santamato, Francesco Panza
The Lancet. Neurology|December 14, 2016
Anti-tau vaccine in Alzheimer's disease: a tentative stepFrancesco Panza, Giancarlo Logroscino
Journal of Alzheimer'S Disease : JAD|October 30, 2014
Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extractVincenzo Solfrizzi, Francesco Panza
The Lancet. Healthy Longevity|September 12, 2022
A multidimensional frailty approach in predicting and preventing dementiaMadia Lozupone, Francesco Panza
Epigenomics|May 13, 2020
Social determinants of late-life depression epigeneticsMadia Lozupone, Francesco Panza
Nature Reviews. Neurology|August 8, 2022
The challenges of anti-tau therapeutics in Alzheimer diseaseFrancesco Panza, Madia Lozupone
Neuroepidemiology|April 23, 2016
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition In Older AgeGiancarlo Logroscino, Francesco Panza
Journal of Alzheimer'S Disease : JAD|November 26, 2013
Mediterranean diet and cognitive decline. A lesson from the whole-diet approach: what challenges lie ahead?Vincenzo Solfrizzi, Francesco Panza
Neural Regeneration Research|July 25, 2023
Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid betaMadia Lozupone, Francesco Panza
European Geriatric Medicine|February 27, 2024
Multidimensional complex frailty phenotypes: epidemiological impact of oral frailty in older ageFrancesco Panza, Madia Lozupone, Vittorio Dibello
Pageof 41